Nursing home-acquired pneumonia: An emergency department treatment algorithm

Current Medical Research and Opinion

Volumn 20, Issue 8, 2004, Pages 1309-1320

  Muder, Robert R ^a   Aghababian, Richard V ^b   Loeb, Mark B ^c   Solot, Jerald A ^d   Higbee, Martin ^e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

Algorithm; Antibiotics; Emergency department; Nursing home; Pneumonia; Treatment

Indexed keywords

AMIKACIN; AZITHROMYCIN; CARBAPENEM; CEFEPIME; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MACROLIDE; MEROPENEM; MOXIFLOXACIN; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ALGORITHM; ANTIBIOTIC THERAPY; ARTICLE; EMERGENCY WARD; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; NURSING HOME; OUTCOMES RESEARCH; PATIENT CARE; PNEUMONIA; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; TREATMENT PLANNING;

EID: 4344716161     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125004376     Document Type: Article

References (53)

1. Jackson MM, Fierer J, Barrett-Connor E, et al. Intensive surveillance for infections in a three-year study of nursing home patients. Am J Epidemiol 1992;135:685-96
2. Loeb M, McGeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999;159:2058-64
3. Vergis EN, Brennen C, Wagener M, Muder RR. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 2001;161:2378-81
4. Feuerberg MA, Mortimore EF, Kramer AM. HCFA study on appropriateness of minimum nurse staffing ratios: interim report. Baltimore (MD): Health Care Financing Administration; 1996
5. Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc 1997;45:302-6
6. Hutt E, Ecord M, Eilertsen TB, et al. Precipitants of emergency room visits and acute hospitalization among short-stay Medicare nursing home residents. J Am Geriatr Soc 2002;50:223-9
7. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000;31:383-421
8. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998;105:319-30
9. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501-13
10. Mylotte JM, Naughton B, Saludades C, Maszarovics Z. Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia. J Am Geriatr Soc 1998;46:1538-44
11. Naughton BJ, Mylotte JM. Treatment guideline for nursing home-acquired pneumonia based on community practice. J Am Geriatr Soc 2000;48:82-8
12. Dempsey CL, Nicolau DP, Sokalski, Shillington AC, Jewell MA, Goliak MK. Nursing home-acquired pneumonia: benchmarking treatment and outcomes in 10 hospitals in the United States. P and T 1999;24:390-6
13. Bartlett JG, Mundy LM. Current concepts: community-acquired pneumonia. New Engl J Med 1995;333(24):1618-24
14. Counsell SR, Tan JS, Dittus RS. Unsuspected pulmonary tuberculosis in a community teaching hospital. Arch Intern Med 1989;149:1274-8
15. Loeb M, Simor AE, Mandell L, et al. Two nursing home outbreaks of respiratory infections with Legionella sainthelensi. J Am Geriatric Soc 1999;47:547-52
16. Nechwatal R, Ehret W, Klatte OJ, Zeissler H-J, Prull A, Lutz H. Nosocomial outbreak of legionellosis in a rehabilitation center. Demonstration of potable water as a source. Infection. 1993;21:235-40
17. Maesaki S, Kohno S, Kog H, et al. An outbreak of Legionnaires' pneumonia in a nursing home. Intern Med 1992;31:508-12
18. Stout JE, Brennen C, Muder RR. Legionnaires' disease in a newly constructed long-term care facility. J Am Geriatr Soc 2000;48:1589-92
19. Sarro, KA, Stout, JE, Muder, RR. Unsuspected endemic Legionnaires' disease in a long term care facility [Abstract #9]. 13th Annual Scientific Meeting. Arlington (VA): The Society for Healthcare Epidemiology of America
20. Troy CJ, Peeling RW, Ellis AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. J Am Med Assoc 1997;277:1214-8
21. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Week Rep 1997;46(RR-9):1-25
22. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl J Med 1994;331:778-84
23. Nichol KL, Wuorenma J, Von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76
24. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. New Engl J Med 1998;338:1861-8
25. Jackson LA, Neuzil KM, Yu O, et al. Vaccine safety datalink. Effectiveness of pneumococcal polysaccharide vaccine in older adults. New Engl J Med 2003;348(18):1747-55
26. Meehan TP, Chua-Reyes JM, Tate J, et al. Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community-acquired or nursing home-acquired pneumonia. Chest 2000;117:1378-85
27. Marrie TJ. Community acquired pneumonia in the elderly. Clin Infect Dis 2000;31:1066-78
28. Cunha BA. Nursing home acquired pneumonia. eMedicine. 2001. [Accessed 12/4/02] Available at URL: http://www.emedicine.com/med/topic3230.htm
29. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18:362-8
30. CRISTI.BNP Trial Results. 2003. [Accessed 7/1/03] Available at URL: http://www.crsti.org/bnpresults.html
31. Narain J, Lofgren J, Warren E, Stead W. Epidemic tuberculosis in a nursing home: a retrospective cohort study. J Am Geriatr Soc 1985;33:258-62
32. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J Am Med Assoc 1997;278(23):2080-4
33. Kahn KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. J Am Med Assoc 1990;264:1969-73
34. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26
35. Bernstein JM. Treatment of community-acquired pneumonia - IDSA guidelines. Infectious Diseases Society of America. Chest 1999;115(Suppl 3):9S-13S
36. Year 2003 ASCAP (Antibiotic Selection for Community-Acquired Pneumonia) Panel Consensus Report®. Community-Acquired Pneumonia (CAP): Evidence-Based Antibiotic Selection and Outcome-Effective Patient Management - Year 2003 Update. [Accessed 1/27/04] Available at URL: http://www.ahcpub.com/ ahc_root_html/hot/archive/ascap2003.html
37. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347-82
38. Katz S, Ford AB, Moskowicz RW, et al. Studies of illness in the aged. The Index of ADL. A standardized measure of biological and physiological function. J Am Med Assoc 1963;185:914-9
39. Muder RR, Brennen C, Swenson DL, Wagener M. Pneumonia in a long-term care facility: A prospective study of outcome. Arch Intern Med 1996;156:2365-70
40. Mehr DR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J Fam Pract 1992;34:585-91
41. Mehr DR, Binder EF, Kruse RL, et al. Predicting mortality in nursing home residents with lower respiratory tract infection: the Missouri LRI Study. J Am Med Assoc 2001;286:2427-36
42. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New Engl J Med 1997;336:243-50
43. Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy, 30th ed. Hyde Park (VT): Antimicrobial Therapy Inc; 2000
44. Kessler RE, Fung-Tomc J. Susceptibility of bacterial isolates to beta-lactam antibiotics from US clinical trials over a 5-year period. Am J Med 1996;100(Suppl 6A):S13-9
45. Thornsberry C, Yee YC. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the US, measured by two methods. Am J Med 1996;100 (Suppl 6A):S26-S38
46. Yee YC, Thornsberry C, Brown SD, et al. A comparative study of the in vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1993;32(Suppl B):S13-S9
47. Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R. In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. Int J Antimicrob Agents 2000; 15(2):111-8
48. Zhanel G. Update on antibiotic resistance: focus on extended spectrum, beta lactamase-producing Enterobacteriaceae. Physician Perspective. Medical Education Network Canada Inc. 2001. [Accessed 12/26/02] Available at URL: http://www.mednet.ca/html/phy-pers9803.htm
49. Sader HS, Gales AC. Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents. Drugs 2001;61:553-64
50. Charles L, Segreti J. Choosing the right macrolide antibiotic: a guide to selection. Drugs 1997;53:349-57
51. Ho A, Cupo J, Gill CL, Gill MA. Fluoroquinolones: from old agents to new agents. J Contin Ed 2000;August:12-22. Available from: http://www.cpha.com/ about/educ/ce/0815ce.pdf [accessed 29 June 2004]
52. Bertino Jr. JS. Integrating fluoroquinolones into the hospital formulary. Pharmacotherapy 2001;21(10s):273s-83s
53. Johnson DM, Biedenbach DJ, Jones RN. Potency and antimicrobial spectrum update for pip/tazo (2000): emphasis on its activity against resistant organism species and generally untested species causing community-acquired respiratory tract infections. Diagn Microbiol Infect Dis 2002;43:49-60